m+Medelevator.RU
← Поиск публикаций
Medical mycology · 2026

Non-Aspergillus invasive mould infections in liver transplant recipients: A French national retrospective case-control study, 2007-2021.

СтатьяМногоцентровое исследованиеНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Melenotte Cléa, Le Hyaric Coralie, Guichon Céline, El Domiaty Nada, Lefebvre François, Durand Francois, Bonnal Christine, Vignals Carole, Lefranc Maxime, Guérin Renaud, Moniot Maxime, Vuotto Fanny, Loridant Séverine, Letscher-Bru Valérie, Tattevin Pierre, Conti Filomena, Monsel Antoine, Gangneux Jean-Pierre, Herbrecht Raoul, Kamar Nassim, Iriart Xavier, Barbaz Mathilde, Chesnay Adélaïde, Weil Delphine, Bellanger Anne-Pauline, Fekkar Arnaud, Botterel Françoise, Saliba Faouzi, Lortholary Olivier, Danion François, Lefort Agnès

Аннотация

BACKGROUND: Non-Aspergillus invasive mould infections (IMIs) are emerging in immunocompromised patients, and liver is the second most commonly organ transplanted worldwide.

METHODS: We conducted a multicenter retrospective case-control (1:1) study of liver transplant (LT) recipients diagnosed with non-Aspergillus IMIs in France between January 2007 and December 2021.

RESULTS: We identified 27/14 332 (0.18%) LT recipients with non-Aspergillus IMIs. Mucorales spp. (48%) were the most common pathogens, followed by Scedosporium spp. (14%), Fusarium spp. (14%), and other IMIs (25%). Lungs were the primary infection site, followed by soft tissues, abdomen, brain, sinuses, heart, and bone. Multivariate analysis showed that a Model for End-stage Liver Disease score > 20 prior to transplantation and primary antifungal prophylaxis (with echinocandins or fluconazole) tended to increase the risk of non-Aspergillus IMIs by nearly threefold ((adjusted Odd Ratio (aOR): 3.73, 95% Confidence Interval (CI) [0.90-15.45], P = .07) and (aOR: 3.93; 95% CI [0.94-16.42], P = .06), respectively). The 6-month mortality rate was 55%. In a Cox survival model, non-Aspergillus IMIs were associated with a threefold increase in mortality risk (Hazard Ratio (HR) : 3.82 [2.01-7.26] P < .001).

CONCLUSION: Non-Aspergillus IMIs are rare but highly fatal infections whose early diagnosis in high-risk liver-transplanted patients is essential. Whether or not recently available molecular tools for diagnosing non-Aspergillus IMIs will improve their prognosis in the liver transplantation setting remains to be studied.

Предметные рубрики MeSH

ИП Урсолов Владлен Сергеевич

ИНН 500118482352 · ОГРНИП 314500117700049

Реквизиты и контакты